Company | Akamai Technologies, Inc. |
Ticker | AKAM (NASDAQ) |
Reporting Period | Q2 2026 (quarter ended June 30, 2026) |
Earnings Date | August 6, 2026 — 4:30 PM ET |
Prepared | August 5, 2026 |
Last Earnings | May 7, 2026 (Q1 2026) |
Key Takeaway: The setup is constructive but nuanced — consensus is a manageable bar on revenue while the EPS guide is wide and below prior expectations, making the real swing factor whether the $1.8B frontier-model deal ramps on schedule and whether management signals additional GPU orders in H2 2026.
Bar: Consensus revenue of ~$1.093B sits comfortably within the $1.075–$1.100B guidance range issued on May 7, representing a low-to-moderate bar on the top line. Non-GAAP EPS consensus of ~$1.58 is near the midpoint of the wide $1.45–$1.65 guide, but the range itself reflects genuine uncertainty around the timing and cost of GPU deliveries in Q2. Guidance/Tone: Management’s posture shifted decisively bullish at Q1 — the $1.8B seven-year CIS commitment (largest deal in company history) and the raised CIS growth outlook to ≥50% constant-currency for FY2026 signal high confidence in the AI infrastructure thesis, even as the wide EPS range acknowledges near-term margin pressure from front-loaded CapEx. Estimate Trajectory: Non-GAAP EPS estimates have drifted lower since the Q1 print (from ~$0.787 pre-print to ~$0.688 currently for Q2), reflecting the CapEx-driven margin compression, while revenue estimates have been broadly stable — a divergence that creates cushion on revenue but risk on EPS if GPU costs run above plan. Stock Setup: AKAM surged ~27% on the Q1 print (May 7–13) but has since retraced to roughly flat vs. the post-earnings close, trading at ~11.8x NTM EV/EBITDA — a meaningful re-rating from ~7.9x a year ago but still well below software/cloud peers, leaving room for further multiple expansion if the CIS ramp is confirmed. Wildcard: The single biggest swing factor is whether management announces additional GPU orders beyond the current $700M H2 2026 CapEx plan — the Q1 call explicitly flagged that the GPU pipeline “significantly exceeds existing and projected inventory,” and any incremental commitment would validate the AI demand thesis and likely re-accelerate the stock.
Key Takeaway: Revenue consensus (~$1.093B) is a low bar within guidance, but non-GAAP EPS (~$1.58) is the bigger swing factor given the wide guide and CapEx-driven margin uncertainty. CIS revenue growth trajectory is the most watched KPI for the AI infrastructure thesis.
KPI | Q1 2026 Actual | Q2 2025 Actual (Prior Year) | Q2 2026 Consensus Estimate | YoY Change | Q2 2026 Guidance | Consensus vs. Guidance Midpoint |
Total Revenue ($M) | $1,073.6 | $1,043.5 | $1,093.1 | +4.8% YoY | $1,075–$1,100M | +0.3% vs. $1,087.5M mid |
CIS Revenue ($M) | $94.6 | $71.5 | $101.7 | +42.3% YoY | ≥50% CC growth FY2026 | N/A (FY guide only) |
Security Revenue ($M) | $589.8 | $551.9 | $600.6 | +8.8% YoY | High single digits CC FY2026 | N/A (FY guide only) |
Delivery Revenue ($M) | $294.2 | $320.1 | $298.2 | −6.8% YoY | Mid-single digit decline CC FY2026 | N/A (FY guide only) |
Non-GAAP EPS (Diluted) | $1.61 | $1.73 | $1.58 | −8.7% YoY | $1.45–$1.65 | +1.9% vs. $1.55 mid |
Non-GAAP Operating Income ($M) | $282.8 | $308.6 | $278.2 | −9.9% YoY | 25–26% non-GAAP op. margin | ~25.5% implied margin |
CapEx — Accrual Basis ($M) | $206.3 | $214.2 | $401.2 | +87.3% YoY | $433–$453M (40–41% of rev) | −10.8% vs. $443M mid |
Source: Visible Alpha Consensus and Actuals Data; Q1 2026 Earnings Release (May 7, 2026); Q1 2026 Earnings Call Transcript (May 7, 2026).
Quarter | Reported ($M) | Consensus ($M) | Surprise % | Result |
Q1 2026 | $1,073.6 | $1,073.9 | 0.0% | In Line |
Q4 2025 | $1,094.9 | $1,077.2 | +1.6% | Beat |
Q3 2025 | $1,054.6 | $1,044.0 | +1.0% | Beat |
Q2 2025 | $1,043.5 | $1,020.8 | +2.2% | Beat |
Q1 2025 | $1,015.1 | $1,012.0 | +0.3% | In Line |
Q4 2024 | $1,019.9 | $1,015.9 | +0.4% | In Line |
Q3 2024 | $1,004.7 | $1,000.4 | +0.4% | In Line |
Q2 2024 | $979.6 | $977.5 | +0.2% | In Line |
Quarter | Reported ($) | Consensus ($) | Surprise % | Result |
Q1 2026 | $1.61 | $1.60 | +0.6% | In Line |
Q4 2025 | $1.84 | $1.77 | +4.0% | Beat |
Q3 2025 | $1.86 | $1.64 | +13.4% | Beat |
Q2 2025 | $1.73 | $1.56 | +11.0% | Beat |
Q1 2025 | $1.70 | $1.57 | +8.3% | Beat |
Q4 2024 | $1.66 | $1.52 | +9.2% | Beat |
Q3 2024 | $1.59 | $1.59 | 0.0% | In Line |
Q2 2024 | $1.58 | $1.53 | +3.3% | Beat |
Pattern: AKAM has beaten non-GAAP EPS consensus in 6 of the last 8 quarters, often by a meaningful margin — however, Q1 2026 and Q3 2024 were in-line prints, and the Q2 2026 EPS guide is unusually wide ($1.45–$1.65), reflecting genuine uncertainty around GPU delivery timing and associated costs. Revenue beats have been modest and consistent, suggesting a conservative guidance philosophy on the top line.
Source: Visible Alpha Consensus and Actuals Data.
Key Takeaway: Guidance has shifted materially since Q4 2025 — the Q1 2026 earnings call delivered a step-change in ambition with the $1.8B CIS deal, raised CIS growth outlook, and a 2027 double-digit revenue growth target, while simultaneously widening the EPS range and dramatically increasing CapEx guidance. No post-earnings guidance revisions have been issued since May 7.
Metric | Initial Guidance (Q1 2026 Earnings — May 7, 2026) | Revised Guidance | Current Consensus | Note |
Q2 2026 Revenue | $1,075–$1,100M | — | $1,093.1M | No post-earnings revision; consensus near high end of range |
Q2 2026 Non-GAAP EPS | $1.45–$1.65 | — | $1.58 | Wide range reflects GPU delivery timing uncertainty; consensus near midpoint |
Q2 2026 Non-GAAP Op. Margin | ~25–26% | — | ~25.5% implied | Margin compression driven by front-loaded GPU CapEx |
Q2 2026 CapEx | $433–$453M (~40–41% of rev) | — | $401.2M | Consensus below guide midpoint; GPU delivery timing key variable |
FY2026 Revenue | $4,445–$4,550M (+6–8% YoY) | — | $4,501.3M | Consensus near midpoint; stable since Q1 print |
FY2026 Non-GAAP EPS | $6.40–$7.15 | — | $6.69 | Wide range; consensus near low end, reflecting CapEx-driven margin pressure |
FY2026 Non-GAAP Op. Margin | ~26% | — | ~26% implied | Narrowed from prior 26–28% range; reflects investment ahead of revenue |
FY2026 CapEx | ~40–42% of revenue (incl. ~$700M for $1.8B deal) | — | $1,157.2M | ↑ Dramatically raised from prior 23–26% guide; driven by landmark CIS deal |
FY2026 CIS Revenue Growth | ≥50% YoY constant currency | — | $475.2M (+50.3% YoY) | ↑ Raised from prior 45–50% CC guide at Q1 earnings |
FY2027 Total Revenue Growth | Double digits YoY (new target introduced Q1 2026) | — | N/A — not yet in VA consensus | ↑ New target; driven by $1.8B deal + $200M deal + pipeline acceleration |
Source: Q1 2026 Earnings Call Transcript and Earnings Release (May 7, 2026); Visible Alpha Consensus and Actuals Data.
Key Takeaway: Revenue estimates have been broadly stable since the Q1 print, tracking guidance well. Non-GAAP EPS estimates have drifted lower (−8–12% since the post-Q1 baseline), reflecting the market’s absorption of the CapEx-driven margin compression — this creates a lower bar on EPS but also means any upside surprise on margins could be a meaningful catalyst.
KPI (Period) | Estimate ~5 Days Post Q1 Earnings (as of May 14, 2026) | Current Consensus (Aug 5, 2026) | Estimate Δ (%) | Initial Guidance (Q1 Call) | Current Guidance | Guidance Δ | Consensus vs. Guidance (%) |
Total Revenue — Q2 2026 | $1,092.9M | $1,093.1M | +0.0% | $1,075–$1,100M | Unchanged | — | +0.3% vs. $1,087.5M mid |
Non-GAAP EPS — Q2 2026 | $1.587 | $1.582 | −0.3% | $1.45–$1.65 | Unchanged | — | +1.9% vs. $1.55 mid |
Total Revenue — FY2026 | $4,504.0M | $4,501.3M | −0.1% | $4,445–$4,550M | Unchanged | — | +0.3% vs. $4,497.5M mid |
Non-GAAP EPS — FY2026 | $6.679 | $6.688 | +0.1% | $6.40–$7.15 | Unchanged | — | +0.9% vs. $6.775 mid |
CIS Revenue — Q2 2026 | $101.7M | $101.7M | 0.0% | ≥50% CC growth FY2026 | Unchanged | — | N/A (FY guide only) |
CIS Revenue — FY2026 | $474.7M | $475.2M | +0.1% | ≥50% CC growth | Unchanged | — | +50.3% YoY implied |
Estimates have been remarkably stable since the Q1 print — both revenue and EPS are essentially unchanged from the post-earnings baseline, suggesting the market has fully digested the guidance and is waiting for Q2 execution confirmation. The key question is whether Q2 CapEx comes in at or below the $433–$453M guide (which would be a positive EPS surprise) or runs above it (which would pressure the low end of the EPS range).
Source: Visible Alpha Consensus and Actuals Data (as-of date: May 14, 2026 for baseline; latest as of August 5, 2026 for current).
Key Takeaway: AKAM’s post-Q1 surge was driven almost entirely by multiple re-rating on the AI infrastructure thesis (EV/EBITDA expanded from ~9.5x to ~11.8x over 6 months), but the stock has given back roughly half its post-earnings gain as the market awaits Q2 execution confirmation. The stock has significantly underperformed XLK since mid-May, suggesting the AI premium is not yet durable without a revenue ramp.
Benchmark Note: XLK (Technology Select Sector SPDR ETF) is used as the sector benchmark. AKAM is classified in the Information Technology sector (internet services/software infrastructure), making XLK the most appropriate peer index. The S&P 500 (SPY) is included as the broad market reference.
AKAM vs. XLK vs. S&P 500 — Indexed to 100 at Q1 2026 Earnings (May 7, 2026). Source: Yahoo Finance / Stock Price Data.
Performance Summary (May 7 – August 4, 2026): AKAM +5.7% | XLK +10.1% | SPY +5.4%. AKAM surged ~38% in the first week post-earnings (May 7–13) on the $1.8B CIS deal announcement, then retraced sharply through June and July as the market digested the CapEx implications and awaited Q2 execution. By late July, AKAM had given back nearly all of its post-earnings gains relative to XLK, which continued to rally on broader AI/tech enthusiasm. The stock has recovered modestly in early August ahead of the print.
Valuation Context: At ~$122, AKAM trades at ~11.8x NTM EV/EBITDA, up from ~7.9x a year ago (+49% multiple expansion). The 12-month price return of +62% has been almost entirely multiple-driven, with EPS estimates broadly flat over the same period. This creates a higher bar for the stock to continue re-rating without tangible CIS revenue acceleration.
Source: Yahoo Finance / Stock Price Data; Visible Alpha Consensus and Actuals Data.
Key Takeaway: Two peers reported or held investor events in the June 6 – August 5, 2026 window with commentary directly applicable to AKAM’s Q2 2026 conditions: Fastly (FSLY) reported Q2 2026 results on August 5 with strong beats across delivery, security, and compute; and Cloudflare (NET) held its Investor Day on June 9 with extensive commentary on AI-driven demand, security urgency, and edge compute trends. Both are broadly positive read-throughs for AKAM, with important caveats noted below.
Scope Note: Only commentary from June 6 – August 5, 2026 that addresses Q2 2026 conditions or forward Q3/H2 2026 outlook is included. Prior-quarter earnings commentary (e.g., Q1 2026 results from peers) is excluded per the user’s instruction.
Fastly reported Q2 2026 results on August 5, 2026, the day before AKAM’s print. Results were strong across all segments and provide a broadly positive read-through for AKAM’s Q2 delivery, security, and compute businesses.
Source: Fastly Q2 2026 Earnings Call Transcript and Earnings Release (August 5, 2026).
Cloudflare held its Investor Day on June 9, 2026, providing extensive forward-looking commentary on Q2 2026 demand conditions and H2 2026 outlook. The commentary is highly applicable to AKAM’s security, delivery, and CIS businesses.
Source: Cloudflare Investor Day Transcript (June 9, 2026).
Source: Public news sources (June–July 2026).
Key Takeaway: The most important post-Q1 development is the $2.6B convertible note offering (May 18, 2026), which signals management is proactively securing capital to fund the unprecedented CapEx cycle driven by the $1.8B CIS deal — a bullish signal on deal pipeline confidence but a near-term dilution/leverage consideration.
Sources: AKAM 8-K filings (May 7, May 13, May 18, 2026); Q1 2026 Earnings Call Transcript; Fastly Q2 2026 Earnings Release; Cloudflare Investor Day Transcript; public news sources.
Key Takeaway: All three insider transactions since Q1 earnings are 10b5-1 planned sales — routine, pre-scheduled dispositions with no discretionary signal. There are no open-market buys or unusual discretionary sales. The absence of any open-market buying is notable given the stock’s post-earnings pullback, but the company itself has been an active buyer (repurchased ~$206M of stock in Q1 2026).
Name | Title | Transaction Type | Shares | Date | Note |
Joseph Paul C | EVP — Global Sales | 10b5-1 Planned Sale | 3,100 shares | July 15, 2026 | Pre-scheduled plan; 31,572 shares remaining post-sale; no discretionary signal |
Blumofe Robert | Chief Technology Officer | 10b5-1 Planned Sale | 243 shares | June 18, 2026 | Very small pre-scheduled sale; 31,006 shares remaining; routine |
Salem-Jackson Kim | EVP, Chief Marketing Officer | 10b5-1 Planned Sale | 2,300 shares | June 10, 2026 | Pre-scheduled plan; 59,210 shares remaining post-sale; no discretionary signal |
All three transactions are 10b5-1 pre-planned sales — none are discretionary open-market sales. The sale sizes are modest relative to remaining holdings (the CTO sold only 243 shares). There are no open-market purchases by insiders since Q1 earnings, which is a mild negative signal given the stock’s pullback from post-earnings highs, but the company’s own buyback program ($975M remaining authorization as of Q1) is the more meaningful capital allocation signal.
Source: SEC Form 4 Filings Database; Form 4 filings for Joseph Paul C (July 15, 2026), Robert Blumofe (June 18, 2026), Kim Salem-Jackson (June 10, 2026).